Talapo Therapeutics, Inc. — Form D
Talapo Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-12. The offering totals $800K, of which $100K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-12-12
- Form: D
- Accession: 0001725002-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $100K
- Remaining: $700K
- Investors: 3
- Date of first sale: 2017-11-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-300507
Issuer
- Name: Talapo Therapeutics, Inc.
- CIK: 0001725002
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2223 AVENIDA DE LA PLAYA, LA JOLLA, CA, 92037
- Phone: 858-754-3201
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Craig Harding | Director | La Jolla, CA |
| Erik Martinez-Hackert | Director | La Jolla, CA |
| Davorka Messmer | Director | La Jolla, CA |
| Neil Senturia | Director | La Jolla, CA |
| Davorka Messmer | Executive Officer | La Jolla, CA |
| Neil Senturia | Executive Officer | La Jolla, CA |
More